United States Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Report 2016

United States Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Report 2016

1 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Overview

1.1 Product Overview and Scope of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons

1.2 Classification of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 USA Market Size Sales (Value) and Revenue (Volume) of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (2011-2021)

1.4.1 USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2011-2021)

1.4.2 USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2011-2021)

2 USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Competition by Manufacturers

2.1 USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Share by Manufactures (2015 and 2016)

2.3 USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Average Price by Manufactures (2015 and 2016)

2.4 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Competitive Situation and Trends

2.4.1 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Concentration Rate

2.4.2 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Type (2011-2016)

3.2 USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Market Share by Type (2011-2016)

3.3 USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Price by Type (2011-2016)

3.4 USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Growth Rate by Type (2011-2016)

4 USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales (Volume) by Application (2011-2016)

4.1 USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Application (2011-2016)

4.2 USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Manufacturers Profiles/Analysis

5.1 Bayer HealthCare AG

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Bayer HealthCare AG Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 AngioCure, In

5.2.2 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 AngioCure, In Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 AVIDAL Vascular GmbH

5.3.2 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 AVIDAL Vascular GmbH Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 AnGes MG, Inc

5.4.2 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 AnGes MG, Inc Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Contego Medical

5.5.2 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Contego Medical Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Elixir Medical

5.6.2 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Elixir Medical Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 eucatech AG

5.7.2 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 eucatech AG Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Lifetech Scientific (Shenzhen) Co., Ltd

5.8.2 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Lifetech Scientific (Shenzhen) Co., Ltd Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Medtronic plc

5.9.2 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Medtronic plc Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Micell Technologies, Inc

5.10.2 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Micell Technologies, Inc Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Nipro Corporation

5.12 NuVascular Technologies Inc

5.13 QT Vascular Ltd

5.14 QualiMed Innovative Medizinprodukte GmbH

5.15 Rontis AG

6 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Manufacturing Cost Analysis

6.1 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Forecast (2016-2021)

10.1 USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue Forecast (2016-2021)

10.2 USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Forecast by Type (2016-2021)

10.3 USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Forecast by Application (2016-2021)

10.4 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons

Table Classification of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons

Figure USA Sales Market Share of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons by Type in 2015

Table Application of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons

Figure USA Sales Market Share of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons by Application in 2015

Figure USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2011-2021)

Figure USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2011-2021)

Table USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales of Key Manufacturers (2015 and 2016)

Table USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Share by Manufacturers

Figure 2016 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Share by Manufacturers

Table USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue by Manufacturers (2015 and 2016)

Table USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue Share by Manufacturers

Table 2016 USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue Share by Manufacturers

Table USA Market Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Average Price of Key Manufacturers (2015 and 2016)

Figure USA Market Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Average Price of Key Manufacturers in 2015

Figure Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share of Top 3 Manufacturers

Figure Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share of Top 5 Manufacturers

Table USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Type (2011-2016)

Table USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Share by Type (2011-2016)

Figure USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share by Type in 2015

Table USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Market Share by Type (2011-2016)

Table USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons by Type (2011-2016)

Table USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Price by Type (2011-2016)

Figure USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Growth Rate by Type (2011-2016)

Table USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Application (2011-2016)

Table USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share by Application (2011-2016)

Figure USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share by Application in 2015

Table USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Growth Rate by Application (2011-2016)

Figure USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Growth Rate by Application (2011-2016)

Table Bayer HealthCare AG Basic Information List

Table Bayer HealthCare AG Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Bayer HealthCare AG Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share (2011-2016)

Table AngioCure, In Basic Information List

Table AngioCure, In Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2011-2016)

Table AngioCure, In Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share (2011-2016)

Table AVIDAL Vascular GmbH Basic Information List

Table AVIDAL Vascular GmbH Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2011-2016)

Table AVIDAL Vascular GmbH Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share (2011-2016)

Table AnGes MG, Inc Basic Information List

Table AnGes MG, Inc Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2011-2016)

Table AnGes MG, Inc Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share (2011-2016)

Table Contego Medical Basic Information List

Table Contego Medical Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2011-2016)

Table Contego Medical Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share (2011-2016)

Table Elixir Medical Basic Information List

Table Elixir Medical Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2011-2016)

Table Elixir Medical Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share (2011-2016)

Table eucatech AG Basic Information List

Table eucatech AG Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2011-2016)

Table eucatech AG Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share (2011-2016)

Table Lifetech Scientific (Shenzhen) Co., Ltd Basic Information List

Table Lifetech Scientific (Shenzhen) Co., Ltd Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2011-2016)

Table Lifetech Scientific (Shenzhen) Co., Ltd Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share (2011-2016)

Table Medtronic plc Basic Information List

Table Medtronic plc Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2011-2016)

Table Medtronic plc Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share (2011-2016)

Table Micell Technologies, Inc Basic Information List

Table Micell Technologies, Inc Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2011-2016)

Table Micell Technologies, Inc Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share (2011-2016)

Table Nipro Corporation Basic Information List

Table Nipro Corporation Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2011-2016)

Table Nipro Corporation Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share (2011-2016)

Table NuVascular Technologies Inc Basic Information List

Table NuVascular Technologies Inc Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2011-2016)

Table NuVascular Technologies Inc Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share (2011-2016)

Table QT Vascular Ltd Basic Information List

Table QT Vascular Ltd Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2011-2016)

Table QT Vascular Ltd Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share (2011-2016)

Table QualiMed Innovative Medizinprodukte GmbH Basic Information List

Table QualiMed Innovative Medizinprodukte GmbH Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2011-2016)

Table QualiMed Innovative Medizinprodukte GmbH Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share (2011-2016)

Table Rontis AG Basic Information List

Table Rontis AG Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2011-2016)

Table Rontis AG Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons

Figure Manufacturing Process Analysis of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons

Figure Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Industrial Chain Analysis

Table Raw Materials Sources of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Major Manufacturers in 2015

Table Major Buyers of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons

Table Distributors/Traders List

Figure USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Production and Growth Rate Forecast (2016-2021)

Figure USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate Forecast (2016-2021)

Table USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Production Forecast by Type (2016-2021)

Table USA Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Consumption Forecast by Application (2016-2021)